S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
All the trading advice you’ve ever received boils down to this (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: World shares mixed after Wall St ends its best month of '23 with big gains
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Salesforce, Big Lots rise; Pure Storage, Cracker Barrel fall, Thursday, 11/30/2023

ConvaTec Group Stock Price, News & Analysis (OTCMKTS:CNVVY)

$11.28
0.00 (0.00%)
(As of 11/30/2023 ET)
Compare
Today's Range
$11.28
$11.28
50-Day Range
$9.95
$11.66
52-Week Range
$9.90
$12.23
Volume
25 shs
Average Volume
1,035 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CNVVY stock logo

About ConvaTec Group Stock (OTCMKTS:CNVVY)

ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence and critical care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

CNVVY Stock Price History

CNVVY Stock News Headlines

The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
ConvaTec Group goes ex-dividend tomorrow
ConvaTec Group PLC 1H Rev $1.06B
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
ConvaTec Raises 2023 Sales View
ConvaTec Group PLC FY Rev $2.07B
ConvaTec Group Plc (CNVVF)
Convatec Group PLC: Director/PDMR Shareholding
ConvaTec Group PLC ADR
ConvaTec Group PLC ADR CNVVY
ConvaTec Group CFO to Step Down in March
See More Headlines
Receive CNVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/13 Dividend
8/17/2023
Dividend Payable
10/13/2023
Today
12/01/2023

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CNVVY
Fax
N/A
Employees
10,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Karim Bitar (Age 58)
    CEO & Director
    Comp: $3.05M
  • Mr. Jonathan Peter Mason (Age 59)
    Group CFO & Director
    Comp: $1.32M
  • Mr. John Haller
    Executive VP and Chief Quality & Operations Officer
  • Dr. Divakar Ramakrishnan Ph.D.
    Executive VP, Chief Technology Officer and Head of Research & Development
  • Ms. Kate Postans
    Vice President of Investor Relations & Corporate Communications
  • Ms. Evelyn Douglas J.D.
    Executive VP, Chief of Corporate Strategy & Business Development and General Counsel
  • Ms. Natalia Kozmina
    Executive VP, Chief Human Resources Officer & ESG Stewardship
  • Ms. Kjersti Grimsrud Biotechnology (Age 62)
    M.Sc., President & COO of Infusion Care
  • Mr. Supratim Bose (Age 71)
    President & COO of Global Emerging Markets
  • Mr. David Shepherd
    President & COO of Global Advanced Wound Care














CNVVY Stock Analysis - Frequently Asked Questions

Should I buy or sell ConvaTec Group stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNVVY shares.
View CNVVY analyst ratings
or view top-rated stocks.

How have CNVVY shares performed in 2023?

ConvaTec Group's stock was trading at $11.11 at the start of the year. Since then, CNVVY shares have increased by 1.5% and is now trading at $11.28.
View the best growth stocks for 2023 here
.

Are investors shorting ConvaTec Group?

ConvaTec Group saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 300 shares, an increase of 200.0% from the October 31st total of 100 shares. Based on an average daily trading volume, of 1,400 shares, the days-to-cover ratio is currently 0.2 days.
View ConvaTec Group's Short Interest
.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group declared a dividend on Thursday, August 3rd. Stockholders of record on Friday, August 18th will be given a dividend of $0.0561 per share on Friday, October 13th. The ex-dividend date of this dividend is Thursday, August 17th.
Read our dividend analysis for CNVVY
.

Is ConvaTec Group a good dividend stock?

ConvaTec Group (OTCMKTS:CNVVY) pays an annual dividend of $0.10 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for CNVVY.

How do I buy shares of ConvaTec Group?

Shares of CNVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CNVVY) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -